Cita APA

Conlon, T. J., Deng, W., Erger, K., Cossette, T., Pang, J., Ryals, R., . . . Hauswirth, W. W. (2013). Preclinical Potency and Safety Studies of an AAV2-Mediated Gene Therapy Vector for the Treatment of MERTK Associated Retinitis Pigmentosa. Mary Ann Liebert, Inc.

Citación estilo Chicago

Conlon, Thomas J., et al. Preclinical Potency and Safety Studies of an AAV2-Mediated Gene Therapy Vector for the Treatment of MERTK Associated Retinitis Pigmentosa. Mary Ann Liebert, Inc, 2013.

Cita MLA

Conlon, Thomas J., et al. Preclinical Potency and Safety Studies of an AAV2-Mediated Gene Therapy Vector for the Treatment of MERTK Associated Retinitis Pigmentosa. Mary Ann Liebert, Inc, 2013.